Nystatin Oral Suspension Shortage

• • Nystatin oral suspension, Leading, 100,000 unit/mL, 473 mL bottle, NDC 69315-0504-47
  • Nystatin oral suspension, Leading, 100,000 unit/mL, 60 mL bottle, NDC 69315-0504-60
  • Nystatin oral suspension, Pharmaceutical Associates, Inc., 100,000 unit/mL, 473 mL bottle, NDC 00121-0868-16
  • Nystatin oral suspension, Pharmaceutical Associates, Inc., 100,000 unit/mL, 60 mL bottle, NDC 00121-0868-02
  • Nystatin oral suspension, Wockhardt USA, 100,000 units/mL, 473 mL bottle, NDC 60432-0537-16 - discontinued
  • Nystatin oral suspension, Wockhardt USA, 100,000 units/mL, 60 mL bottle, NDC 60432-0537-60 - discontinued

• • Leading Pharma did not provide a reason for the shortage.
  • Pharmaceutical Associates did not provide a reason for the shortage.
  • Wockhardt discontinued nystatin suspension and the company is distributing remaining inventory (short-dated).

• • There is insufficient supply for usual ordering

Estimated Resupply Dates

• • Leading Pharma has nystatin 100,000 unit/mL suspension in 60 mL and 473 mL bottles on allocation.
  • Pharmaceutical Associates has nystatin 100,000 unit/mL suspension in 60 mL and 473 mL bottles on back order and the company cannot estimate a release date.